P24821 (TENA_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 158.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Tenascin Short name=TN Alternative name(s): Cytotactin GMEM GP 150-225 Glioma-associated-extracellular matrix antigen Hexabrachion JI Myotendinous antigen Neuronectin Tenascin-C Short name=TN-C | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 2201 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Extracellular matrix protein implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity as well as neuronal regeneration. Promotes neurite outgrowth from cortical neurons grown on a monolayer of astrocytes. Ligand for integrins alpha-8/beta-1, alpha-9/beta-1, alpha-V/beta-3 and alpha-V/beta-6. |
| Subunit structure | Homohexamer; disulfide-linked. A homotrimer may be formed in the triple coiled-coil region and may be stabilized by disulfide rings at both ends. Two of such half-hexabrachions may be disulfide linked within the central globule. Interacts with CSPG4. Ref.8 |
| Subcellular location | |
| Induction | By TGFB1. |
| Sequence similarities | Belongs to the tenascin family. Contains 15 EGF-like domains. Contains 1 fibrinogen C-terminal domain. Contains 15 fibronectin type-III domains. |
Ontologies
Alternative products
| This entry describes 6 isoforms produced by alternative splicing. [Align] [Select] Note: Isoforms are produced in a tissue- and time-specific manner during development. | ||||||
| Isoform 1 (identifier: P24821-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P24821-2) Also known as: HT-5; The sequence of this isoform differs from the canonical sequence as follows: 1072-1435: Missing. 1527-1617: Missing. | ||||||
| Isoform 3 (identifier: P24821-3) The sequence of this isoform differs from the canonical sequence as follows: 1072-1435: Missing. | ||||||
| Isoform 4 (identifier: P24821-4) Also known as: HT-33; The sequence of this isoform differs from the canonical sequence as follows: 1527-1617: Missing. | ||||||
| Isoform 5 (identifier: P24821-5) The sequence of this isoform differs from the canonical sequence as follows: 1072-1617: Missing. | ||||||
| Isoform 6 (identifier: P24821-6) Also known as: P31; The sequence of this isoform differs from the canonical sequence as follows: 1072-1708: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 22 | 22 | Ref.2 | ||||||||||||||||||||||||
| Chain | 23 – 2201 | 2179 | Tenascin | PRO_0000007741 | |||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||
| Domain | 174 – 186 | 13 | EGF-like 1; incomplete | ||||||||||||||||||||||||
| Domain | 186 – 217 | 32 | EGF-like 2 | ||||||||||||||||||||||||
| Domain | 217 – 248 | 32 | EGF-like 3 | ||||||||||||||||||||||||
| Domain | 248 – 280 | 33 | EGF-like 4 | ||||||||||||||||||||||||
| Domain | 280 – 311 | 32 | EGF-like 5 | ||||||||||||||||||||||||
| Domain | 311 – 342 | 32 | EGF-like 6 | ||||||||||||||||||||||||
| Domain | 342 – 373 | 32 | EGF-like 7 | ||||||||||||||||||||||||
| Domain | 373 – 404 | 32 | EGF-like 8 | ||||||||||||||||||||||||
| Domain | 404 – 435 | 32 | EGF-like 9 | ||||||||||||||||||||||||
| Domain | 435 – 466 | 32 | EGF-like 10 | ||||||||||||||||||||||||
| Domain | 466 – 497 | 32 | EGF-like 11 | ||||||||||||||||||||||||
| Domain | 497 – 528 | 32 | EGF-like 12 | ||||||||||||||||||||||||
| Domain | 528 – 559 | 32 | EGF-like 13 | ||||||||||||||||||||||||
| Domain | 559 – 590 | 32 | EGF-like 14 | ||||||||||||||||||||||||
| Domain | 590 – 621 | 32 | EGF-like 15 | ||||||||||||||||||||||||
| Domain | 622 – 710 | 89 | Fibronectin type-III 1 | ||||||||||||||||||||||||
| Domain | 713 – 801 | 89 | Fibronectin type-III 2 | ||||||||||||||||||||||||
| Domain | 802 – 891 | 90 | Fibronectin type-III 3 | ||||||||||||||||||||||||
| Domain | 892 – 983 | 92 | Fibronectin type-III 4 | ||||||||||||||||||||||||
| Domain | 984 – 1071 | 88 | Fibronectin type-III 5 | ||||||||||||||||||||||||
| Domain | 1075 – 1162 | 88 | Fibronectin type-III 6 | ||||||||||||||||||||||||
| Domain | 1164 – 1253 | 90 | Fibronectin type-III 7 | ||||||||||||||||||||||||
| Domain | 1255 – 1344 | 90 | Fibronectin type-III 8 | ||||||||||||||||||||||||
| Domain | 1348 – 1435 | 88 | Fibronectin type-III 9 | ||||||||||||||||||||||||
| Domain | 1439 – 1526 | 88 | Fibronectin type-III 10 | ||||||||||||||||||||||||
| Domain | 1528 – 1617 | 90 | Fibronectin type-III 11 | ||||||||||||||||||||||||
| Domain | 1619 – 1708 | 90 | Fibronectin type-III 12 | ||||||||||||||||||||||||
| Domain | 1709 – 1797 | 89 | Fibronectin type-III 13 | ||||||||||||||||||||||||
| Domain | 1798 – 1885 | 88 | Fibronectin type-III 14 | ||||||||||||||||||||||||
| Domain | 1886 – 1973 | 88 | Fibronectin type-III 15 | ||||||||||||||||||||||||
| Domain | 1975 – 2190 | 216 | Fibrinogen C-terminal | ||||||||||||||||||||||||
| Coiled coil | 118 – 145 | 28 | Potential | ||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||
| Modified residue | 70 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||
| Modified residue | 72 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||
| Glycosylation | 38 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 166 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 184 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||||||||||||||||||
| Glycosylation | 327 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 788 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1018 | 1 | N-linked (GlcNAc...) Ref.11 | ||||||||||||||||||||||||
| Glycosylation | 1034 | 1 | N-linked (GlcNAc...) Ref.11 | ||||||||||||||||||||||||
| Glycosylation | 1079 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||||||||||||||||||
| Glycosylation | 1093 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||||||||||||||||||
| Glycosylation | 1119 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1184 | 1 | N-linked (GlcNAc...) Ref.11 | ||||||||||||||||||||||||
| Glycosylation | 1210 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1261 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||||||||||||||||||
| Glycosylation | 1275 | 1 | N-linked (GlcNAc...) Ref.11 | ||||||||||||||||||||||||
| Glycosylation | 1301 | 1 | N-linked (GlcNAc...) Ref.10 Ref.11 | ||||||||||||||||||||||||
| Glycosylation | 1366 | 1 | N-linked (GlcNAc...) Ref.11 | ||||||||||||||||||||||||
| Glycosylation | 1392 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1445 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1455 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1485 | 1 | N-linked (GlcNAc...) Ref.10 Ref.11 | ||||||||||||||||||||||||
| Glycosylation | 1534 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1809 | 1 | N-linked (GlcNAc...) Ref.9 | ||||||||||||||||||||||||
| Glycosylation | 2162 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||||||||||||||||||
| Disulfide bond | 190 ↔ 200 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 194 ↔ 205 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 207 ↔ 216 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 221 ↔ 231 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 225 ↔ 236 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 238 ↔ 247 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 252 ↔ 263 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 256 ↔ 268 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 270 ↔ 279 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 284 ↔ 294 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 288 ↔ 299 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 301 ↔ 310 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 315 ↔ 325 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 319 ↔ 330 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 332 ↔ 341 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 346 ↔ 356 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 350 ↔ 361 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 363 ↔ 372 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 377 ↔ 387 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 381 ↔ 392 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 394 ↔ 403 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 408 ↔ 418 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 412 ↔ 423 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 425 ↔ 434 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 439 ↔ 449 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 443 ↔ 454 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 456 ↔ 465 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 470 ↔ 480 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 474 ↔ 485 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 487 ↔ 496 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 501 ↔ 511 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 505 ↔ 516 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 518 ↔ 527 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 532 ↔ 542 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 536 ↔ 547 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 549 ↔ 558 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 563 ↔ 573 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 567 ↔ 578 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 580 ↔ 589 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 594 ↔ 604 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 598 ↔ 609 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 611 ↔ 620 | By similarity | |||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||
| Alternative sequence | 1072 – 1708 | 637 | Missing in isoform 6. | VSP_001415 | |||||||||||||||||||||||
| Alternative sequence | 1072 – 1617 | 546 | Missing in isoform 5. | VSP_001414 | |||||||||||||||||||||||
| Alternative sequence | 1072 – 1435 | 364 | Missing in isoform 2 and isoform 3. | VSP_001412 | |||||||||||||||||||||||
| Alternative sequence | 1527 – 1617 | 91 | Missing in isoform 2 and isoform 4. | VSP_001413 | |||||||||||||||||||||||
| Natural variant | 213 | 1 | G → S. Corresponds to variant rs7020958 [ dbSNP | Ensembl ]. | VAR_055778 | |||||||||||||||||||||||
| Natural variant | 539 | 1 | Q → R. Ref.1 Ref.3 Ref.7 Corresponds to variant rs1757095 [ dbSNP | Ensembl ]. | VAR_024266 | |||||||||||||||||||||||
| Natural variant | 605 | 1 | V → I. Corresponds to variant rs3827816 [ dbSNP | Ensembl ]. | VAR_024267 | |||||||||||||||||||||||
| Natural variant | 680 | 1 | Q → R. Ref.2 Corresponds to variant rs1061494 [ dbSNP | Ensembl ]. | VAR_024268 | |||||||||||||||||||||||
| Natural variant | 850 | 1 | D → H. Corresponds to variant rs3748169 [ dbSNP | Ensembl ]. | VAR_055779 | |||||||||||||||||||||||
| Natural variant | 1677 | 1 | I → L. Ref.1 Ref.3 Ref.4 Ref.7 Corresponds to variant rs2104772 [ dbSNP | Ensembl ]. | VAR_060738 | |||||||||||||||||||||||
| Natural variant | 1781 | 1 | A → T. Corresponds to variant rs2274750 [ dbSNP | Ensembl ]. | VAR_020169 | |||||||||||||||||||||||
| Natural variant | 2008 | 1 | E → Q. Ref.1 Ref.2 Ref.3 Ref.4 Ref.7 Corresponds to variant rs13321 [ dbSNP | Ensembl ]. | VAR_014665 | |||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||
| Sequence conflict | 244 | 1 | Missing in CAA39628. Ref.2 | ||||||||||||||||||||||||
| Sequence conflict | 370 | 1 | V → L no nucleotide entry Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 370 | 1 | V → L in AAA88083. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 370 | 1 | V → L in CAA55309. Ref.4 | ||||||||||||||||||||||||
| Sequence conflict | 1066 | 1 | R → H no nucleotide entry Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 1066 | 1 | R → H in AAA88083. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 1066 | 1 | R → H in AAA52703. Ref.7 | ||||||||||||||||||||||||
| Sequence conflict | 1600 – 1608 | 9 | SGFTQGHQT → LWLHPRASN no nucleotide entry Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 1600 – 1608 | 9 | SGFTQGHQT → LWLHPRASN in AAA88083. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 1600 – 1608 | 9 | SGFTQGHQT → LWLHPRASN in AAA52703. Ref.7 | ||||||||||||||||||||||||
| Sequence conflict | 2054 | 1 | F → FLH no nucleotide entry Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 2054 | 1 | F → FLH in AAA88083. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 2055 | 1 | W → L in AAA52703. Ref.7 | ||||||||||||||||||||||||
| Sequence conflict | 2140 – 2143 | 4 | YKGA → TRG in CAA39628. Ref.2 | ||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||
| Beta strand | 807 – 813 | 7 | |||||||||||||||||||||||||
| Beta strand | 819 – 824 | 6 | |||||||||||||||||||||||||
| Helix | 827 – 829 | 3 | |||||||||||||||||||||||||
| Beta strand | 831 – 839 | 9 | |||||||||||||||||||||||||
| Beta strand | 842 – 844 | 3 | |||||||||||||||||||||||||
| Beta strand | 847 – 852 | 6 | |||||||||||||||||||||||||
| Beta strand | 857 – 860 | 4 | |||||||||||||||||||||||||
| Beta strand | 868 – 877 | 10 | |||||||||||||||||||||||||
| Beta strand | 885 – 890 | 6 | |||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats." Nies D.E., Hemesath T.J., Kim J.H., Gulcher J.R., Stefansson K. J. Biol. Chem. 266:2818-2823(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS ARG-539; LEU-1677 AND GLN-2008. |
| [2] | "Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies." Siri A., Carnemolla B., Saginati M., Leprini A., Casari G., Baralle F., Zardi L. Nucleic Acids Res. 19:525-531(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 4 AND 5), PROTEIN SEQUENCE OF 23-32, VARIANTS ARG-680 AND GLN-2008. Tissue: Fetal brain and Melanoma. |
| [3] | "Structure of the human hexabrachion (tenascin) gene." Gulcher J.R., Nies D.E., Alexakos M.J., Ravikant N.A., Sturgill M.E., Marton L.S., Stefansson K. Proc. Natl. Acad. Sci. U.S.A. 88:9438-9442(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS ARG-539; LEU-1677 AND GLN-2008. |
| [4] | "Human tenascin gene. Structure of the 5'-region, identification, and characterization of the transcription regulatory sequences." Gherzi R., Carnemolla B., Siri A., Ponassi M., Balza E., Zardi L. J. Biol. Chem. 270:3429-3434(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS LEU-1677 AND GLN-2008. |
| [5] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by northern and in situ hybridization using species specific cDNA probes." Glumoff V., Savontaus M., Vehanen J., Vuorio E. Biochim. Biophys. Acta 1219:613-622(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 46-125 (ISOFORMS 1/2/3/4/5/6). Tissue: Fetal cartilage. |
| [7] | "An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites." Gulcher J.R., Nies D.E., Marton L.S., Stefansson K. Proc. Natl. Acad. Sci. U.S.A. 86:1588-1592(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 431-2055 (ISOFORMS 1 AND 6), VARIANTS ARG-539; LEU-1677 AND GLN-2008. Tissue: Glioblastoma. |
| [8] | "Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules." Burg M.A., Tillet E., Timpl R., Stallcup W.B. J. Biol. Chem. 271:26110-26116(1996) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CSPG4. |
| [9] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1809, MASS SPECTROMETRY. Tissue: Plasma. |
| [10] | "Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry." Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F. Proteomics 8:3833-3847(2008) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184; ASN-1079; ASN-1093; ASN-1261; ASN-1301; ASN-1485 AND ASN-2162, MASS SPECTROMETRY. Tissue: Milk. |
| [11] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1018; ASN-1034; ASN-1184; ASN-1275; ASN-1301; ASN-1366 AND ASN-1485, MASS SPECTROMETRY. Tissue: Liver. |
| [12] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [13] | "Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein." Leahy D.J., Hendrickson W.A., Aukhil I., Erickson H.P. Science 258:987-991(1992) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF FIBRONECTIN TYPE-III 3. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M55618 mRNA. Translation: AAA88083.1. X56160 mRNA. Translation: CAA39628.1. X78565 mRNA. Translation: CAA55309.1. AL162425 Genomic DNA. Translation: CAI15110.1. X80280 mRNA. No translation available. M24630 mRNA. Translation: AAA52703.1. | ||||||||||||||||||||||||
| IPI | IPI00031008. IPI00220211. IPI00220213. IPI00220214. IPI00220216. IPI01015608. | ||||||||||||||||||||||||
| PIR | A32160. I38337. | ||||||||||||||||||||||||
| RefSeq | NP_002151.2. NM_002160.3. | ||||||||||||||||||||||||
| UniGene | Hs.143250. Hs.734766. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P24821. | ||||||||||||||||||||||||
| SMR | P24821. Positions 94-1976, 1980-2189. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| STRING | 9606.ENSP00000265131. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P24821. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 281185495. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | P24821. | ||||||||||||||||||||||||
| PRIDE | P24821. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000340094; ENSP00000344400; ENSG00000041982. ENST00000345230; ENSP00000345861; ENSG00000041982. ENST00000346706; ENSP00000344555; ENSG00000041982. ENST00000350763; ENSP00000265131; ENSG00000041982. ENST00000535648; ENSP00000438152; ENSG00000041982. ENST00000537320; ENSP00000443478; ENSG00000041982. | ||||||||||||||||||||||||
| GeneID | 3371. | ||||||||||||||||||||||||
| KEGG | hsa:3371. | ||||||||||||||||||||||||
| UCSC | uc004bjj.4. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 3371. | ||||||||||||||||||||||||
| GeneCards | GC09M117782. | ||||||||||||||||||||||||
| HGNC | HGNC:5318. TNC. | ||||||||||||||||||||||||
| HPA | CAB004592. HPA004823. | ||||||||||||||||||||||||
| MIM | 187380. gene. | ||||||||||||||||||||||||
| neXtProt | NX_P24821. | ||||||||||||||||||||||||
| PharmGKB | PA35103. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | NOG12793. | ||||||||||||||||||||||||
| HOVERGEN | HBG008949. | ||||||||||||||||||||||||
| InParanoid | P24821. | ||||||||||||||||||||||||
| KO | K06252. | ||||||||||||||||||||||||
| OMA | GQRSCPN. | ||||||||||||||||||||||||
| OrthoDB | EOG4MSCX9. | ||||||||||||||||||||||||
| PhylomeDB | P24821. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Pathway_Interaction_DB | syndecan_4_pathway. Syndecan-4-mediated signaling events. | ||||||||||||||||||||||||
| Reactome | REACT_111102. Signal Transduction. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P24821. | ||||||||||||||||||||||||
| Bgee | P24821. | ||||||||||||||||||||||||
| CleanEx | HS_TNC. | ||||||||||||||||||||||||
| Genevestigator | P24821. | ||||||||||||||||||||||||
| GermOnline | ENSG00000041982. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 2.60.40.10. 15 hits. 3.90.215.10. 1 hit. 4.10.530.10. 1 hit. | ||||||||||||||||||||||||
| InterPro | IPR000742. EG-like_dom. IPR013032. EGF-like_CS. IPR013111. EGF_extracell. IPR014716. Fibrinogen_a/b/g_C_1. IPR014715. Fibrinogen_a/b/g_C_2. IPR002181. Fibrinogen_a/b/g_C_dom. IPR003961. Fibronectin_type3. IPR013783. Ig-like_fold. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF07974. EGF_2. 7 hits. PF00147. Fibrinogen_C. 1 hit. PF00041. fn3. 15 hits. PF12661. hEGF. 3 hits. [Graphical view] | ||||||||||||||||||||||||
| SMART | SM00181. EGF. 12 hits. SM00186. FBG. 1 hit. SM00060. FN3. 15 hits. [Graphical view] | ||||||||||||||||||||||||
| SUPFAM | SSF56496. Fibrinogen_a/b/g_C. 1 hit. SSF49265. FN_III-like. 15 hits. | ||||||||||||||||||||||||
| PROSITE | PS00022. EGF_1. 15 hits. PS01186. EGF_2. 15 hits. PS50026. EGF_3. 5 hits. PS00514. FIBRINOGEN_C_1. False negative. PS51406. FIBRINOGEN_C_2. 1 hit. PS50853. FN3. 15 hits. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| EvolutionaryTrace | P24821. | ||||||||||||||||||||||||
| GenomeRNAi | 3371. | ||||||||||||||||||||||||
| NextBio | 13334. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | TENA_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P24821 Secondary accession number(s): C9IYT7 Q5T7S3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
